Sequenom, Inc. (NASDAQ:SQNM) today announced new positive data from the prospective clinical studies using the Company’s noninvasive SEQureDx™ technology, enabling the detection of fetal aneuploidy from maternal blood. The data presented today consist of 459 new, high prevalence samples from the prospective, blinded studies performed at Sequenom, bringing the total number of samples studied to […]
Sequenom, Inc. (NASDAQ:SQNM) today announced it is terminating its exchange offer to acquire all of the outstanding shares of common stock of EXACT Sciences Corporation (NASDAQ:EXAS) without accepting for exchange or exchanging any shares of EXACT Sciences common stock. Sequenom had previously announced that it would terminate the exchange offer if EXACT Sciences entered into […]
— New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy — MENLO PARK, Calif., Jan. 27 — Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that it has acquired a co-exclusive worldwide license from Stanford University to develop cell-free […]
Most Comprehensive Tests for Diagnosing and Characterizing the Genomic Causes of Childhood Developmental Disorders, including Autism Spectrum Disorders MUKILTEO, Wash., Jan. 26, 2009 — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), has entered into a new partnership with Lenetix, a New York based laboratory, to co-market […]
PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced that its ViaCord Research Institute™ (VRI™), which focuses on supporting science, technology and medical treatments using cord blood stem cells, will support the University of Massachusetts Medical School (UMMS) in its research efforts into the potential use […]
Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, today announced that it has received permission to investigate alternatives to its announced merger with the Elitech Group. Nanogen requested and Elitech agreed to waive the restrictions in the Share Exchange Agreement related to Nanogen’s right to investigate alternatives because Nanogen and Elitech believe it […]
REYKJAVIK, Iceland, Jan. 20 — deCODE genetics (Nasdaq: DCGN) announced today that it has entered into an agreement with NBI, an Icelandic financial institution, pursuant to which NBI has purchased deCODE’s auction rate securities for an aggregate price of $11 million. Pursuant to the agreement, deCODE has the call option to require NBI to sell […]
Edinburgh – 20 Jan 2009 – Lab901 today announced shipment of its 50th TapeStation™ instrument to its new Canadian distributor, Inverness Medical. Inverness Medical Canada joins the growing team of international distributors for Lab901’s first ScreenTape® product which automates multiplex PCR detection and analysis. ‘We are delighted to have reached this milestone in such a […]
PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced the extension of a research collaboration between its ViaCord Research Institute™ (VRI™) and The University of Texas M.D. Anderson Cancer Center. The collaboration underscores VRI’s commitment to advancing technologies that multiply cord blood stem cells, with the […]
Gene Express, Inc. announced today that it has entered into an Distribution Agreement with Funakoshi Co., Ltd. for the distribution of Gene Express, Inc.’s Standardized RT-PCR reagents (StaRT-PCR(TM)) and research molecular diagnostic tools. The non-exclusive agreement provides Funakoshi with the rights to distribute in Japan. Jonathan Rowe, PhD, Chief Operating Officer for Gene Express, Inc., […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
